{"id":47673,"date":"2022-08-25T17:02:04","date_gmt":"2022-08-25T15:02:04","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/ccgroup-clinical-decision-support-system-quantifies-covid-effect-on-decreased-healthcare-utilization-in-the-united-states\/"},"modified":"2022-08-25T17:02:04","modified_gmt":"2022-08-25T15:02:04","slug":"ccgroup-clinical-decision-support-system-quantifies-covid-effect-on-decreased-healthcare-utilization-in-the-united-states","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/ccgroup-clinical-decision-support-system-quantifies-covid-effect-on-decreased-healthcare-utilization-in-the-united-states\/","title":{"rendered":"CCGroup Clinical Decision Support System Quantifies \u201cCOVID Effect\u201d on Decreased Healthcare Utilization in the United States"},"content":{"rendered":"<div>\n<p>SAN MATEO, Calif.&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.cavegroup.com%2F&amp;esheet=52825838&amp;newsitemid=20220825005058&amp;lan=en-US&amp;anchor=Cave+Consulting+Group%2C+Inc.&amp;index=1&amp;md5=c3791eb01e3633bdf2a0290b785d59f5\" rel=\"nofollow noopener\" shape=\"rect\">Cave Consulting Group, Inc.<\/a> (CCGroup) initiated this study to quantify the COVID Effect\u2019s impact on decreased U.S. healthcare utilization. Decreased utilization is a function of at least two components: (1) decreased volume of medical condition episodes seen by PCPs and specialists; and (2) decreased volume of key medical services (MedMarkers\u2122) used to diagnose and\/or treat those medical condition episodes that are seen by PCPs and specialists. \u201cWe examine here only the initial component, decreased volume of medical condition episodes,\u201d stated <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fcavegroup.com%2Fcompany-leadership%2F&amp;esheet=52825838&amp;newsitemid=20220825005058&amp;lan=en-US&amp;anchor=Dr.+Douglas+Cave&amp;index=2&amp;md5=99b64f7e9c001f3f1124cab0b81fa161\" rel=\"nofollow noopener\" shape=\"rect\">Dr. Douglas Cave<\/a>, President of CCGroup.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220825005058\/en\/808308\/5\/CCG-AAA_800x434_transparent.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220825005058\/en\/808308\/21\/CCG-AAA_800x434_transparent.jpg\"><\/a><\/p>\n<p>\nDr. Cave continued, \u201cOverall medical condition episode volume decreased 17% due to the COVID Effect.\u201d\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nPrimary care physicians (PCPs) versus specialists:<\/p>\n<ul class=\"bwlistcircle\">\n<li>\nPCP episode volume decreased 13% (range: -10% to -15%).\n<\/li>\n<li>\nSpecialist episode volume decreased 18% (range: +3.5% to -49%).\n<\/li>\n<\/ul>\n<\/li>\n<li>\nAcute versus chronic medical condition episode volume:<\/p>\n<ul class=\"bwlistcircle\">\n<li>\nAcute medical condition episode volume decreased 19%.\n<\/li>\n<li>\nChronic medical condition episode volume decreased 16%.\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>\nDr. Cave stated, \u201cWe used the Cave Grouper\u2122 and CCGroup Clinical Decision Support System\u2122 (CDSS) to quantify the COVID Effect. The CDSS examines provider performance and adherence to evidence-based medicine. By PCP and specialty type, the CDSS examines clinical rows of practice for many medical conditions. A clinical row is comprised of a medical condition, an associated MedMarker\u2122, and an established Clinical MedMarker Protocol Range\u2122.\u201d\n<\/p>\n<p>\nMedMarkers\u2122 are process of care quality measures, well-defined in clinical guidelines, and also are the key services most associated with cost-of-care in treating a medical condition. Clinical MedMarker Protocol Ranges\u2122 are achievable and clinically appropriate ranges of clinical practice for a MedMarker\u2122. Ranges are developed by clinical responses obtained from CCGroup National Specialist Panels.\n<\/p>\n<p>\nThe CCGroup Clinical Decision Support System is used by CCGroup clients for the following strategic needs: limit prior authorization programs to outlier provider groups whose ordering patterns differ significantly from clinically appropriate ranges of clinical practice; implement value based payment based on both cost and quality of care; steer members to \u2018preferred\u2019 specialists by medical condition procedure based on cost, quality, and access to care; and appropriate care clinical transformation.\n<\/p>\n<p>\n\u201cSignificant decreases in MedMarker\u2122 utilization may be attributed to changes in provider group practice patterns or to the COVID Effect. Therefore, decreases attributed to the COVID Effect need to be quantified to better understand changes in provider practice patterns variation over time,\u201d defined Dr. Cave.\n<\/p>\n<p>\nA conclusion from this study is that the reduction in episode volume affects the CDSS number of clinical rows a provider group has to evaluate clinical performance. \u201cFor example, there currently are 80 clinical rows to evaluate orthopedists\u2019 clinical practice. Lowest-episode volume orthopedic groups generally have <span class=\"bwuline\">between 5 and 25 clinical rows<\/span> with <span class=\"bwuline\">&gt;<\/span>10 medical condition episodes (in the baseline years 2017, 2018, and 2019). However, the COVID Effect in 2020 reduces this number to <span class=\"bwuline\">between 3 and 15 clinical rows<\/span> with <span class=\"bwuline\">&gt;<\/span>10 medical condition episodes,\u201d mentioned Dr. Cave.\n<\/p>\n<p>\nResults for the lowest-episode volume orthopedic groups imply clinical performance will be judged somewhat differently in 2020 as compared to baseline years (as there are fewer clinical rows to evaluate CDSS performance). This finding is not as relevant for the higher-episode volume orthopedic groups.\n<\/p>\n<p>\nFor this study, CCGroup used the CCGroup-CMS Innovator Project and the 32 million Medicare fee-for-service (FFS) beneficiaries claims data for 2017, 2018, 2019, 2020. CCGroup controlled for differences in Medicare beneficiary case mix by using a marketbasket of relevant, prevalent medical conditions for PCPs and each specialty type. Each marketbasket of medical conditions accounts for greater than 80% of episodes treated by a specialty type. Also, CCGroup used 2017, 2018, and 2019 medical condition episode volume to control for other potential environmental factors affecting utilization over time.\n<\/p>\n<p>\n<b>About Cave Consulting Group, Inc. (CCGroup)<\/b>\n<\/p>\n<p>\nCCGroup is a software and consulting firm located in San Mateo, California. The company is focused on improving the efficiency (cost-of-care) and effectiveness (quality-of-care) of the healthcare delivery system. Senior management of CCGroup has assessed the performance of physicians and hospitals for over 30 years for health systems, physician groups, clinically-integrated networks, health plans, HMOs, TPAs, and employers.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nMr. Yuri Alexandrian, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.cavegroup.com&amp;esheet=52825838&amp;newsitemid=20220825005058&amp;lan=en-US&amp;anchor=CCGroup&amp;index=3&amp;md5=536e1ed72aca7b46a9e267b47898412e\" rel=\"nofollow noopener\" shape=\"rect\">CCGroup<\/a> (<a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;&#58;&#x59;&#97;&#x6c;&#101;&#x78;&#97;&#x6e;&#100;&#x72;&#105;&#x61;&#110;&#x40;&#99;&#x61;&#118;&#x65;&#103;&#x72;o&#x75;p&#x2e;c&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#89;&#x61;l&#101;&#x78;a&#110;&#x64;r&#x69;&#x61;&#110;&#x40;c&#97;&#x76;e&#103;&#x72;o&#x75;&#x70;&#46;&#x63;&#x6f;&#109;<\/a>)\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN MATEO, Calif.&#8211;(BUSINESS WIRE)&#8211;Cave Consulting Group, Inc. (CCGroup) initiated this study to quantify the COVID Effect\u2019s impact on decreased U.S. healthcare utilization. Decreased utilization is a function of at least two components: (1) decreased volume of medical condition episodes seen by PCPs and specialists; and (2) decreased volume of key medical services (MedMarkers\u2122) used to &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/ccgroup-clinical-decision-support-system-quantifies-covid-effect-on-decreased-healthcare-utilization-in-the-united-states\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47673","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CCGroup Clinical Decision Support System Quantifies \u201cCOVID Effect\u201d on Decreased Healthcare Utilization in the United States - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/ccgroup-clinical-decision-support-system-quantifies-covid-effect-on-decreased-healthcare-utilization-in-the-united-states\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CCGroup Clinical Decision Support System Quantifies \u201cCOVID Effect\u201d on Decreased Healthcare Utilization in the United States - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SAN MATEO, Calif.&#8211;(BUSINESS WIRE)&#8211;Cave Consulting Group, Inc. (CCGroup) initiated this study to quantify the COVID Effect\u2019s impact on decreased U.S. healthcare utilization. Decreased utilization is a function of at least two components: (1) decreased volume of medical condition episodes seen by PCPs and specialists; and (2) decreased volume of key medical services (MedMarkers\u2122) used to ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/ccgroup-clinical-decision-support-system-quantifies-covid-effect-on-decreased-healthcare-utilization-in-the-united-states\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-25T15:02:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220825005058\/en\/808308\/21\/CCG-AAA_800x434_transparent.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ccgroup-clinical-decision-support-system-quantifies-covid-effect-on-decreased-healthcare-utilization-in-the-united-states\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ccgroup-clinical-decision-support-system-quantifies-covid-effect-on-decreased-healthcare-utilization-in-the-united-states\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"CCGroup Clinical Decision Support System Quantifies \u201cCOVID Effect\u201d on Decreased Healthcare Utilization in the United States\",\"datePublished\":\"2022-08-25T15:02:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ccgroup-clinical-decision-support-system-quantifies-covid-effect-on-decreased-healthcare-utilization-in-the-united-states\\\/\"},\"wordCount\":669,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ccgroup-clinical-decision-support-system-quantifies-covid-effect-on-decreased-healthcare-utilization-in-the-united-states\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220825005058\\\/en\\\/808308\\\/21\\\/CCG-AAA_800x434_transparent.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ccgroup-clinical-decision-support-system-quantifies-covid-effect-on-decreased-healthcare-utilization-in-the-united-states\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ccgroup-clinical-decision-support-system-quantifies-covid-effect-on-decreased-healthcare-utilization-in-the-united-states\\\/\",\"name\":\"CCGroup Clinical Decision Support System Quantifies \u201cCOVID Effect\u201d on Decreased Healthcare Utilization in the United States - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ccgroup-clinical-decision-support-system-quantifies-covid-effect-on-decreased-healthcare-utilization-in-the-united-states\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ccgroup-clinical-decision-support-system-quantifies-covid-effect-on-decreased-healthcare-utilization-in-the-united-states\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220825005058\\\/en\\\/808308\\\/21\\\/CCG-AAA_800x434_transparent.jpg\",\"datePublished\":\"2022-08-25T15:02:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ccgroup-clinical-decision-support-system-quantifies-covid-effect-on-decreased-healthcare-utilization-in-the-united-states\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ccgroup-clinical-decision-support-system-quantifies-covid-effect-on-decreased-healthcare-utilization-in-the-united-states\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ccgroup-clinical-decision-support-system-quantifies-covid-effect-on-decreased-healthcare-utilization-in-the-united-states\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220825005058\\\/en\\\/808308\\\/21\\\/CCG-AAA_800x434_transparent.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220825005058\\\/en\\\/808308\\\/21\\\/CCG-AAA_800x434_transparent.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ccgroup-clinical-decision-support-system-quantifies-covid-effect-on-decreased-healthcare-utilization-in-the-united-states\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CCGroup Clinical Decision Support System Quantifies \u201cCOVID Effect\u201d on Decreased Healthcare Utilization in the United States\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CCGroup Clinical Decision Support System Quantifies \u201cCOVID Effect\u201d on Decreased Healthcare Utilization in the United States - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/ccgroup-clinical-decision-support-system-quantifies-covid-effect-on-decreased-healthcare-utilization-in-the-united-states\/","og_locale":"en_US","og_type":"article","og_title":"CCGroup Clinical Decision Support System Quantifies \u201cCOVID Effect\u201d on Decreased Healthcare Utilization in the United States - Pharma Trend","og_description":"SAN MATEO, Calif.&#8211;(BUSINESS WIRE)&#8211;Cave Consulting Group, Inc. (CCGroup) initiated this study to quantify the COVID Effect\u2019s impact on decreased U.S. healthcare utilization. Decreased utilization is a function of at least two components: (1) decreased volume of medical condition episodes seen by PCPs and specialists; and (2) decreased volume of key medical services (MedMarkers\u2122) used to ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/ccgroup-clinical-decision-support-system-quantifies-covid-effect-on-decreased-healthcare-utilization-in-the-united-states\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-25T15:02:04+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220825005058\/en\/808308\/21\/CCG-AAA_800x434_transparent.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/ccgroup-clinical-decision-support-system-quantifies-covid-effect-on-decreased-healthcare-utilization-in-the-united-states\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/ccgroup-clinical-decision-support-system-quantifies-covid-effect-on-decreased-healthcare-utilization-in-the-united-states\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"CCGroup Clinical Decision Support System Quantifies \u201cCOVID Effect\u201d on Decreased Healthcare Utilization in the United States","datePublished":"2022-08-25T15:02:04+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ccgroup-clinical-decision-support-system-quantifies-covid-effect-on-decreased-healthcare-utilization-in-the-united-states\/"},"wordCount":669,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ccgroup-clinical-decision-support-system-quantifies-covid-effect-on-decreased-healthcare-utilization-in-the-united-states\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220825005058\/en\/808308\/21\/CCG-AAA_800x434_transparent.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/ccgroup-clinical-decision-support-system-quantifies-covid-effect-on-decreased-healthcare-utilization-in-the-united-states\/","url":"https:\/\/pharma-trend.com\/en\/ccgroup-clinical-decision-support-system-quantifies-covid-effect-on-decreased-healthcare-utilization-in-the-united-states\/","name":"CCGroup Clinical Decision Support System Quantifies \u201cCOVID Effect\u201d on Decreased Healthcare Utilization in the United States - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ccgroup-clinical-decision-support-system-quantifies-covid-effect-on-decreased-healthcare-utilization-in-the-united-states\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ccgroup-clinical-decision-support-system-quantifies-covid-effect-on-decreased-healthcare-utilization-in-the-united-states\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220825005058\/en\/808308\/21\/CCG-AAA_800x434_transparent.jpg","datePublished":"2022-08-25T15:02:04+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/ccgroup-clinical-decision-support-system-quantifies-covid-effect-on-decreased-healthcare-utilization-in-the-united-states\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/ccgroup-clinical-decision-support-system-quantifies-covid-effect-on-decreased-healthcare-utilization-in-the-united-states\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/ccgroup-clinical-decision-support-system-quantifies-covid-effect-on-decreased-healthcare-utilization-in-the-united-states\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220825005058\/en\/808308\/21\/CCG-AAA_800x434_transparent.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220825005058\/en\/808308\/21\/CCG-AAA_800x434_transparent.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/ccgroup-clinical-decision-support-system-quantifies-covid-effect-on-decreased-healthcare-utilization-in-the-united-states\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"CCGroup Clinical Decision Support System Quantifies \u201cCOVID Effect\u201d on Decreased Healthcare Utilization in the United States"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47673","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47673"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47673\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47673"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47673"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47673"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}